Bills To Boost Generic, Biosimilar Competition Headed To Biden’s Desk

Destined for the president’s signature are two bipartisan bills that aim to boost generic and biosimilar competition by restricting eligibility for drug exclusivity and by increasing confidence in biosimilars. The House on Wednesday (April 14) passed the Advancing Education on Biosimilars Act and the Ensuring Innovation Act. The Senate passed both bills in March. The Ensuring Innovation Act (S. 415) narrows the definition of drugs that are considered new chemical entities. The bill’s sponsors, Sens. Bill Cassidy (R-LA), Tina...